The Blood Collection Tubes Market is to Touch $3.2 billion by 2030; Increasing Incidence of Chronic Diseases and Advancements in Healthcare Diagnostics propels market growth.

The Blood Collection Tubes Market size is estimated to reach $3.2 billion by 2030, growing at a CAGR of 5.7% during the forecast period 2023-2030, according to a recent report published by IndustryARC, titled, “Blood Collection Tubes Market – By Product Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes, and Others), By Material Type (Plastic, and Glass), By End Use (Hospitals & Clinics, R&D Centers, Diagnostic Centers, and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2023-2030” Increasing Incidence of Chronic Diseases and Advancements in Healthcare Diagnostics are fueling the growth of the Blood Collection Tubes industry during the forecast period.

North America is projected to dominate the blood collection tubes market, capturing a significant share of 36% in 2023. This is primarily due to the strong presence of key players such as Becton Dickinson & Company in Franklin Lakes, New Jersey. The region’s favorable healthcare policies and the increasing number of patients in the U.S. requiring EDTA tubes for blood collection further contribute to market growth. The U.S. has seen a surge in demand for blood collection tubes within healthcare systems, driven by advancements in diagnostic technologies catering to a wide array of patient populations. Additionally, the rising number of surgeries across various medical specialties has further boosted the use of blood collection tubes.

The rising prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and various types of cancer, is a key factor driving the growth of the blood collection tubes market. These conditions often necessitate regular diagnostic testing for monitoring and management, and blood collection tubes are crucial for obtaining samples for a variety of laboratory tests, including complete blood counts, blood chemistry, and disease-specific markers. As the global burden of chronic diseases continues to escalate, the demand for blood collection tubes in diagnostic applications is expected to rise, further fueling market expansion. Despite advancements in overall health, the World Health Organization (WHO) reported in 2023 that if current trends persist, chronic diseases like cardiovascular conditions, cancer, diabetes, and respiratory illnesses will account for 86% of the 90 million deaths annually by 2050.

Technological advancements in healthcare diagnostics, including enhanced laboratory testing methods and the development of novel diagnostic assays, have significantly driven the growth of the blood collection tubes market. The increasing demand for more precise and comprehensive diagnostic information has led to the creation of specialized blood collection tubes with unique additives, coatings, and properties designed for specific testing needs. Innovations in molecular diagnostics and personalized medicine have further broadened the applications of these tubes. As diagnostic capabilities continue to advance, the need for advanced blood collection tubes that ensure sample integrity and support a wide variety of diagnostic tests is anticipated to fuel continued market growth.

• February 2022: Abacus dx introduced the latest addition to Streck's trusted blood collection tube range, the RNA Complete BCT.

• August 2022: Immunexpress, Pty Ltd. launched the SeptiCyte RAPID EDTA blood-compatible cartridges in the European market. These cartridges are designed for use with EDTA blood collection tubes in clinical hematology procedures.

 

Key companies profiled in the Blood Collection Tubes Market are Sekisui Chemical Co., Ltd., QIAGEN N.V., Bio – X, CML Biotech, Hebei Xinle Sci &Tech Co., Ltd., and others.